The ROE as of September 2024 (TTM) for Century Therapeutics, Inc. (IPSC) is -65.37%

According to Century Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -65.37%. This represents a change of 295.72% compared to the average of -16.52% of the last 4 quarters.

Century Therapeutics, Inc. (IPSC) Historical ROE (quarterly & annually)

How has IPSC ROE performed in the past?

The mean historical ROE of Century Therapeutics, Inc. over the last ten years is 35.55%. The current -65.37% ROE has changed -283.90% with respect to the historical average. Over the past ten years (40 quarters), IPSC's ROE was at its highest in in the March 2021 quarter at 20.04%. The ROE was at its lowest in in the December 2023 quarter at -21.33%.

Century Therapeutics, Inc. (IPSC) ROE by Quarter and Year

Discovering the peaks and valleys of Century Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Century Therapeutics, Inc. (IPSC) Average ROE

How has IPSC ROE performed in the past?

The current ROE of Century Therapeutics, Inc. (IPSC) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Century Therapeutics, Inc. (IPSC) ROE vs. Peers

How is IPSC’s ROE compared to its peers?

Century Therapeutics, Inc.’s ROE is greater than Edgewise Therapeutics, Inc. (-28.01%), greater than C4 Therapeutics, Inc. (-44.60%), greater than Mineralys Therapeutics, Inc. (-42.61%), greater than Cullinan Oncology, Inc. (-28.37%), greater than Passage Bio, Inc. (-70.73%), greater than Homology Medicines, Inc. (-100.91%), greater than Generation Bio Co. (-92.86%), greater than Stoke Therapeutics, Inc. (-57.89%), greater than Erasca, Inc. (-131.94%), greater than NGM Biopharmaceuticals, Inc. (-76.46%), greater than Keros Therapeutics, Inc. (-44.73%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than Kezar Life Sciences, Inc. (-54.50%), greater than Nkarta, Inc. (-28.83%), greater than Theseus Pharmaceuticals, Inc. (-24.51%), greater than aTyr Pharma, Inc. (-56.83%), greater than Relay Therapeutics, Inc. (-43.66%), greater than Blueprint Medicines Corporation (-85.25%),

Build a custom stock screener for Century Therapeutics, Inc. (IPSC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Century Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Century Therapeutics, Inc. (IPSC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Century Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.